
Join to view full profile
920 Santa Fe DrWeatherford, TX 76086
Phone+1 817-759-7000
Fax+1 817-759-7027
Dr. Laine is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterResidency, Radiation Oncology, 2010 - 2014
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2009 - 2010
Icahn School of Medicine at Mount SinaiClass of 2009
Certifications & Licensure
AZ State Medical License 2018 - 2028
TX State Medical License 2015 - 2027
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- 1 citationsConcurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.Yuanyuan Zhang, Aaron M Laine, Puneeth Iyengar, Kenneth D Westover, Jonathan E Dowell
International Journal of Radiation Oncology, Biology, Physics. 2025-06-01 - 18 citationsStereotactic Ablative Radiotherapy for High-Risk Prostate Cancer-a Prospective Multi-level MRI-based Dose Escalation Trial.Raquibul Hannan, Samer Salamekh, Neil Desai, Aurelie Garant, Michael R. Folkert
International Journal of Radiation Oncology, Biology, Physics. 2021-11-10 - 36 citationsA Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer.Michael R. Folkert, Michael J. Zelefsky, Raquibul Hannan, Neil Desai, Yair Lotan
International Journal of Radiation Oncology, Biology, Physics. 2021-09-01
Press Mentions
Stereotactic Radiation Highly Effective for Kidney CancerMay 4th, 2017
Neutrophils Are Key to Harnessing Anti-Tumor Immune Response from Radiation Therapy, Study FindsSeptember 21st, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: